• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition, Swallowing and Saliva
      • Activities of Daily Living and Occupational Therapy
      • Muscles, Mobility and Exercise
      • Respiratory Care
      • Speech and Communication
      • Voice Preservation
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
  • Members
    • Member Registration
    • Forgot Password

Admin

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

@rachel

Profile

Registered: 13 years ago


Forums

Topics Started: 2

Replies Created: 0

Forum Role: Keymaster

Primary Sidebar

Advocacy

  • Advocacy Toolkit

Approved Drugs

  • Nuedexta
  • Radicava/Edaravone
  • Riluzole/Tiglutik
  • Rozebalamin / Methylcobalamin
  • Tofersen/Qalsody

Drugs in Development

  • AB Science – Masitinib
  • NurOwn
  • Clene Nanomedicine – CNM-Au8
  • ILB
  • Kadimastem – AstroRx
  • Neuronata-R / Lenzumestrocel
  • NeuroSense – PrimeC
  • NP001
  • Prilenia Therapeutics – Pridopidine
  • SOD1 Therapies & Trials
  • SPG302
  • Regulatory T Cell Enhancing Therapies
  • Ulefnersen

Care services

  • Genetic Counselling & Testing
  • Mental Health Support
  • Nursing and Symptom Management
  • Nutrition, Swallowing and Saliva
  • Activities of Daily Living and Occupational Therapy
  • Muscles, Mobility and Exercise
  • Respiratory Care
  • Speech and Communication
  • Support for Family & Caregivers
  • Technology

Support for members

  • Alliance Support Grant
  • About the meetings

Programs & Events

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day Calendar
  • March of Faces
  • International Symposium

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Meetings
  • Awards

Upcoming Events

Nov 19
12:00 pm - 1:00 pm CST

Les Turner ALS Foundation Webinar: The Caregiver’s Journey

Nov 20
7:45 am - 5:15 pm MST

Canadian Society of Palliative Medicine: Palliative Horizons – Clinical Approaches to ALS and Parkinson’s

Nov 24
9:00 am - 10:30 am EST

Annual General Meeting

Dec 5
December 5 - December 6

Alliance Meeting

Dec 7
December 7 - December 8

Allied Professionals Forum

View Calendar

  • Jorge Melo, Brazil

    Jorge Melo, Brazil

  • Jean Waters, UK

    Jean Waters, UK

  • Fernando Ocampo Cardona, Colombia

    Fernando Ocampo Cardona, Colombia

  • Rolf Mauch, Switzerland

    Rolf Mauch, Switzerland

  • David Solomon, UK

    David Solomon, UK

  • Sébastien Batiot, France

    Sébastien Batiot, France

  • Claudia Gotti, Brazil

    Claudia Gotti, Brazil

  • Daniel Hare, USA

    Daniel Hare, USA

  • John Sweeney, USA

    John Sweeney, USA

  • Sam Hayden-Harler, UK

    Sam Hayden-Harler, UK

  • Brian Lovell, Australia

    Brian Lovell, Australia

  • Sally Pauls, USA

    Sally Pauls, USA

  • Emilienne Verhaegen, Belgium

    Emilienne Verhaegen, Belgium

  • Charlie Dourney, USA

    Charlie Dourney, USA

  • Jean

    Jean
    jean

  • Erwin Coppejans, Belgium

    Erwin Coppejans, Belgium

  • Natalya Rybakova, Russia

    Natalya Rybakova, Russia

  • Jason Goodman, USA

    Jason Goodman, USA

  • Mauricio Dorin, Argentina

    Mauricio Dorin, Argentina

  • Willi Klein, UK

    Willi Klein, UK

  • Alfredo Santos, Colombia

    Alfredo Santos, Colombia

  • Orly Dichoso, Canada

    Orly Dichoso, Canada

  • Ann Nicol, USA

    Ann Nicol, USA

  • H. Todd Kelly, USA

    H. Todd Kelly, USA

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • Frank Taylor, USA

    Frank Taylor, USA

  • Shera Mukherjee, India

    Shera Mukherjee, India

  • Carlos Alberto Báez Murillo, Colombia

    Carlos Alberto Báez Murillo, Colombia

  • Gudjon Sigurdsson, Iceland

    Gudjon Sigurdsson, Iceland

  • Peng Yi-Wen, Taiwan

    Peng Yi-Wen, Taiwan

  • JP

    JP

  • Juvenal Bayona Romero, Colombia

    Juvenal Bayona Romero, Colombia

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • João Marcos Andrietta, Brazil

    João Marcos Andrietta, Brazil

  • Anthony Lynch, Australia

    Anthony Lynch, Australia

  • Liam Dwyer, England

    Liam Dwyer, England

  • Olga Cosentino, Argentina

    Olga Cosentino, Argentina

  • Den Haag, Netherlands

    Den Haag, Netherlands

  • Danny Reviers, Belgium

    Danny Reviers, Belgium
    DannyReviers

  • Rudiger Hanemann, Germany

    Rudiger Hanemann, Germany

  • Camilla Heiberg Freiberg, Denmark

    Camilla Heiberg Freiberg, Denmark

  • Lucy Lintott, Scotland

    Lucy Lintott, Scotland

  • Olga, Argentina

    Olga, Argentina

  • Timothy Holman, Switzerland

    Timothy Holman, Switzerland

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

  • Antonio Ventriglia, Belgium

    Antonio Ventriglia, Belgium

  • Hanne Stenmose, Denmark

    Hanne Stenmose, Denmark

  • Imelda Arenas, Colombia

    Imelda Arenas, Colombia

  • Paul Launer, USA

    Paul Launer, USA

  • Jette Odgaard Villemoes, Denmark

    Jette Odgaard Villemoes, Denmark

Learn more about the March of Faces

Coronavirus (COVID-19) Resources

Instructions

First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

If you have already registered, please use the details provided to log in using this form.

Drugs No Longer in Development

  • AMX0035
  • Reldesemtiv
  • Arimoclomol
  • TUDCA

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login